The NAVIFY Infection Management solution is being designed to enable timely and optimal therapy based on guidelines for patients with serious infections. The solution helps streamline workflows, provides contextualized insights, and supports analytics to track key metrics.
Learn more by visiting us at booth #4258 at HIMSS21.
Click the banner above to see how Roche will be participating at HIMSS21
Roche will join the line-up of world-class presenters and programming at HIMSS21, the annual conference of the Healthcare Information and Management Systems Society (HIMSS). HIMSS has served the global health community for more than 60 years, with focused operations across North America, Europe, the United Kingdom, the Middle East and Asia-Pacific.
This year, to accommodate the health and safety of participants, HIMSS21 will be a hybrid in-person and virtual event scheduled August 9 – 13 in Las Vegas, Nevada. As usual, it is expected to draw a wide variety of attendees from across the healthcare ecosystem, including CIOs and senior executives, IT professionals, providers, government officials, healthcare innovators, consultants and market suppliers.
HIMSS21 will include a wide variety of education, networking and professional development opportunities, as well as hundreds of symposia, forums and presentations featuring industry leaders, highly-regarded keynote speakers and specialty programs. Attendees can expect insightful explorations on the state of patient engagement and empowerment, improved clinical decision-making, enhancing healthcare operations and delivery and trust and adoption of high-tech advances in healthcare delivery.
Among the featured presentations at HIMSS21 will be a panel discussion entitled The Co-Evolution of Participatory and Personalized Medicine (Tuesday, August 10 at 2:07 pm – 2:37 pm PST).
Presented by Moritz Hartmann, Global Head of Roche Information Solutions, this webinar will explore the strong and growing trend in personalized healthcare services. From the many ways that patients are increasingly involved in managing their own care, ranging from web searches of their symptoms and interpreting their test results, to the most high-tech genome-directed precision medicine.
At HIMSS21, Roche will announce a new product currently in development for the NAVIFY portfolio, aimed at helping to redefine healthcare professionals’ experience in managing acute infections by bringing antimicrobial stewardship insights to the bedside.
EMR integration
Enriched patient 360° view
Care pathway navigation
Clinical decision support, and real-time collaboration, depending on connection speed
Easy and customizable report generation to track and improve KPIs (clinical, financial)
In the wake of the COVID-19 pandemic, acute infections have contributed to increasing healthcare burdens. These include increased rates of hospitalization, length-of-stay and readmission. To help address these challenges, this new product will help leverage our shared, deep understanding of clinical science and medical care with the goal of helping to improve patient care by capturing opportunities that lie in integrating and activating healthcare data.
The NAVIFY Infection Management*, a digital acute infection management solution with an initial focus on Antimicrobial Stewardship, is being designed to enable timely and optimal therapy based on guidelines for patients with serious infections. The solution helps streamline workflows, provides contextualized insights, and supports analytics to track key metrics.
Areas where NAVIFY Infection Management* will deliver value to the healthcare ecosystem include:
References & notes
* Product in development
Interested in learning more?
Request a demo